Feedback / Questions
CD40HVac - LinKinVax
https://www.globenewswire.com/news-release/2024/12/09/2993602/0/en/EnnoDC-presents-preliminary-data-for-immunotherapy-candidate-CD40-HVac-in-HPV-oropharyngeal-cancer-at-ESMO-IO-2024.html
Dec 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next